Characteristics, outcomes of US children, adolescents with multisystem inflammatory syndrome in children compared with severe COVID-19
What The Study Did:
National COVID-19 registry data are used in this study to describe the epidemiology, clinical characteristics, complications, and hospital and postdischarge outcomes of pediatric patients with multisystem inflammatory syndrome in children (MIS-C) and to compare each in patients with severe COVID-19.
Adrienne G. Randolph, M.D., of Boston Children’s Hospital, is the corresponding author.
To access the embargoed study:
Visit our For The Media website at this link
Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
The full studyis linked to this news release.
Embed this link to provide your readers free access to the full-text article
This link will be live at the embargo time
JAMA Network Media Relations